Influenza Hemagglutinin (HA) Peptide: Precision in Immunoprecipitation and Protein Detection

Principle Overview: The Power of the HA Tag Peptide

The Influenza Hemagglutinin (HA) Peptide, a synthetic nine-amino acid tag (YPYDVPDYA), has become an essential tool in molecular biology and biochemistry for the detection and purification of HA-tagged proteins. Serving as a universal epitope tag for protein detection, this peptide enables highly specific immunoprecipitation and competitive elution of HA fusion proteins, streamlining workflows across diverse protein interaction and signaling studies. Its high purity (>98%) and exceptional solubility in water, DMSO, and ethanol [source_type: product_spec][source_link: https://www.apexbt.com/influenza-hemagglutinin-ha-peptide.html] make it compatible with a wide variety of assay formats, from conventional immunoprecipitation with Anti-HA antibody to advanced chemoproteomic profiling.

As highlighted in recent reviews and original research, the HA tag peptide has advanced from a simple molecular label to a strategic enabler in complex protein–protein interaction mapping, ubiquitination, and the mechanistic dissection of disease pathways [Unleashing Mechanistic Precision] [Precision Tag for E3 Ligase Research]. The reliability and specificity of the HA tag sequence continues to make it the epitope of choice for both discovery and translational pipelines.

Step-by-Step Workflow: Enhancing Immunoprecipitation with the HA Tag Peptide

Optimizing immunoprecipitation with Anti-HA antibody depends on several key factors—peptide purity, concentration, and elution conditions. Below is a data-driven protocol, integrating product specifications and workflow recommendations:

Protocol Parameters

• assay: Immunoprecipitation elution | value_with_unit: 1 mg/mL HA peptide in PBS | applicability: Elution of HA-tagged proteins from Anti-HA beads | rationale: Sufficient competitive binding to Anti-HA antibody for high-yield elution | source_type: workflow_recommendation
• assay: Peptide dissolution | value_with_unit: ≥46.2 mg/mL in water, ≥55.1 mg/mL in DMSO | applicability: Preparing concentrated stock solutions | rationale: Ensures full peptide solubilization for consistent results | source_type: product_spec [source_link: https://www.apexbt.com/influenza-hemagglutinin-ha-peptide.html]
• assay: Elution incubation | value_with_unit: 30 minutes at 4°C | applicability: Incubation of bead–protein complexes with HA peptide | rationale: Maximizes specific elution while minimizing background | source_type: workflow_recommendation
• assay: Storage | value_with_unit: Desiccated at -20°C | applicability: Maintaining peptide stability | rationale: Prevents peptide degradation and loss of activity | source_type: product_spec [source_link: https://www.apexbt.com/influenza-hemagglutinin-ha-peptide.html]

For best results, freshly prepare HA peptide solutions immediately prior to use to avoid loss of activity due to long-term storage in solution [source_type: product_spec][source_link: https://www.apexbt.com/influenza-hemagglutinin-ha-peptide.html].

Key Innovation from the Reference Study

The recent study by Lu Hu et al. (Nature Chemical Biology) leveraged HA-tagged constructs to investigate the regulation of mutant IDH1-R132H activity by autopalmitoylation. Using HA-tagged IDH1 and sensitive immunoprecipitation workflows, the researchers mapped post-translational modifications and protein–protein interactions central to cancer cell metabolism. Notably, their workflow emphasized the need for robust competitive binding to Anti-HA antibody for reliable elution and downstream proteomic analysis. This underscores the practical value of high-purity, highly soluble Influenza Hemagglutinin (HA) Peptide for dissecting complex regulatory networks in cancer research [source_type: paper][source_link: https://doi.org/10.1038/s41589-025-02131-8].

Advanced Applications and Comparative Advantages

The Influenza Hemagglutinin (HA) Peptide, available from APExBIO, is distinguished by its >98% purity and sequence fidelity [source_type: product_spec][source_link: https://www.apexbt.com/influenza-hemagglutinin-ha-peptide.html]. This ensures minimal background and high signal-to-noise ratios in both immunoprecipitation and protein detection assays. Comparative studies demonstrate that HA peptide-based elution achieves efficient recovery of HA-tagged proteins with low off-target effects, outperforming less-specific tags in stringent workflows [Scenario-Driven Guidance]. The peptide’s compatibility with mass spectrometry-based proteomics further enables high-throughput mapping of protein–protein and protein–lipid interactions, as in the reference study’s chemoproteomic profiling of autopalmitoylation events [source_type: paper][source_link: https://doi.org/10.1038/s41589-025-02131-8].

In recent years, the HA tag peptide has expanded beyond classical immunoprecipitation. For example, its use in advanced exosome biogenesis studies and mechanistic dissection of E3 ligase activity is highlighted in both [Unleashing Mechanistic Precision] and [E3 Ligase Mechanisms], which complement the scenario-driven workflow focus of [Reliable HA Tag Performance]. These resources collectively position the HA tag as a tool of choice for researchers demanding both versatility and reproducibility.

Troubleshooting and Optimization Tips

• Low yield in HA-tagged protein elution: Increase HA peptide concentration incrementally (e.g., 2–5 mg/mL) if initial elution is inefficient; verify peptide solubility prior to use [source_type: workflow_recommendation].
• High background or non-specific binding: Incorporate additional wash steps post-immunoprecipitation and use freshly prepared peptide solutions; verify that Anti-HA antibody is not saturated [source_type: workflow_recommendation].
• Peptide precipitation or solubility issues: Always dissolve the HA tag peptide in DMSO or ethanol if water solubility is insufficient for required concentrations [source_type: product_spec][source_link: https://www.apexbt.com/influenza-hemagglutinin-ha-peptide.html].
• Signal loss in downstream detection (e.g., western blot): Minimize elution time and avoid repeated freeze–thaw cycles of peptide stocks. Store desiccated at -20°C and aliquot as needed [source_type: product_spec][source_link: https://www.apexbt.com/influenza-hemagglutinin-ha-peptide.html].

Future Outlook: Implications and Evolving Best Practices

The continued integration of the Influenza Hemagglutinin (HA) Peptide into high-resolution proteomics and metabolic pathway studies is set to accelerate discoveries in cellular signaling and disease mechanisms. As shown in the IDH1-R132H autopalmitoylation study, combining HA tag-based workflows with advanced chemoproteomic profiling can reveal previously inaccessible post-translational modifications and regulatory vulnerabilities in cancer cells [source_type: paper]. The precision and reliability of APExBIO's HA tag peptide ensure it will remain a staple in both fundamental and translational research, providing a foundation for the next generation of protein interaction mapping and targeted therapeutic development.

For detailed product information and ordering, visit the Influenza Hemagglutinin (HA) Peptide page at APExBIO.